Orem A, Değer O, Kulan K, Onder E, Kiran E, Uzunosmanoğlu D
Department of Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Clin Biochem. 1995 Apr;28(2):171-3. doi: 10.1016/0009-9120(94)00078-a.
Lipoprotein (a) [Lp (a)] is an atherogenic particle that structurally resembles a low-density lipoprotein (LDL) particle but contains a molecule of apolipoprotein (a) attached to apolipoprotein B-100 by a disulfide bond. Because of the fact that elevated plasma levels of Lp (a) have been shown to be an independent risk factor for coronary artery disease (CAD), we determined plasma Lp(a) levels in CAD for Turkish population, and compared them with previous findings of some developed countries.
The mean plasma Lp (a) levels in CAD group (mean +/- SD; 0.41 +/- 0.21, g/L) was found approximately twofold higher than that of the control group (0.21 +/- 0.17 g/L). Also, it was found to be higher than the mean levels of CAD group in the other populations described in previous reports. But CAD prevalence in the Turkish population is lower than in those of developed countries, especially the United States.
We concluded that the interaction between plasma Lp (a) levels and many other factors such as face and heredity affecting development of CAD may show different effects for development of CAD in each of those populations separately.
脂蛋白(a)[Lp(a)]是一种致动脉粥样硬化颗粒,其结构类似于低密度脂蛋白(LDL)颗粒,但含有一个通过二硫键与载脂蛋白B-100相连的载脂蛋白(a)分子。由于血浆Lp(a)水平升高已被证明是冠状动脉疾病(CAD)的独立危险因素,我们测定了土耳其人群CAD患者的血浆Lp(a)水平,并将其与一些发达国家先前的研究结果进行比较。
CAD组的平均血浆Lp(a)水平(均值±标准差;0.41±0.21 g/L)约为对照组(0.21±0.17 g/L)的两倍。此外,该水平高于先前报道中其他人群CAD组的平均水平。但土耳其人群中CAD的患病率低于发达国家,尤其是美国。
我们得出结论,血浆Lp(a)水平与影响CAD发生发展的许多其他因素(如种族和遗传)之间的相互作用,可能在这些人群中对CAD的发生发展分别产生不同的影响。